Skip to content
Governance Register

← US public companies

Moonlake Immunotherapeutics

SEC CIK 1821586 · MLTX · last insider filing 2026-06-23

Directors (from insider filings)

NameCapacity as filedFilings
BVF Partners L P/IL Director filed 2022 - 2026
BVF INC/IL Director filed 2022 - 2026
Biotechnology Value Fund II LP Director filed 2022 - 2026
Lampert Mark N Director filed 2022 - 2026
Biotechnology Value Trading Fund OS LP Director filed 2022 - 2026
BVF Partners OS Ltd. Director filed 2022 - 2026
BVF I GP LLC Director filed 2022 - 2026
BVF II GP LLC Director filed 2022 - 2026
BVF GP Holdings LLC Director filed 2022 - 2026
Biotechnology Value Fund L P Director filed 2022 - 2026
Moukheibir Catherine Director filed 2022 - 2026
Loy Spike Director filed 2022 - 2026
Xavier Ramnik Director filed 2022 - 2026
Phillips Andrew John Director filed 2022 - 2026
Santos da Silva Jorge Director · Chief Executive Officer filed 2022 - 2026
Chen Bihua Director · CEO and Chairman filed 2020 - 2025
Sturge Simon Director filed 2022 - 2025
Lassen Kara Director filed 2022 - 2022
Helix Holdings LLC Director filed 2020 - 2022
Chang Nancy T Director filed 2020 - 2020
Schmid John P. Director filed 2020 - 2020
Lewis Will Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Bodenstedt Matthias Chief Financial Officer filed 2022 - 2026
Reich Kristian Chief Scientific Officer filed 2022 - 2026
Scollins Jay Chief Financial Officer filed 2020 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.